Jump to content

Joseph Heitman

From Wikipedia, the free encyclopedia
Joseph Heitman
Joseph Heitman in his laboratory
NationalityAmerican
Occupation(s)geneticist, microbiologist, and molecular biologist
AwardsEdward Novitski Prize (2019)
Academic background
Alma materUniversity of Chicago, Cornell and Rockefeller Universities
Doctoral advisorPeter Model, Norton Zinder
Other advisorsMichael N. Hall
Academic work
DisciplineMicrobiology, Genetics, Infectious Diseases
Sub-disciplineMycology, Genomics, Evolution, Molecular Biology
InstitutionsDuke University School of Medicine
Notable studentsChristina M. Hull (postdoc 2000-2003)

Joseph Heitman is an American physician-scientist focused on research in genetics, microbiology, and infectious diseases. He is the James B. Duke Professor and Chair of the Department of Molecular Genetics and Microbiology at Duke University School of Medicine.[1]

Education and career

[edit]

Joseph Heitman grew up in southwestern Michigan and attended Portage Northern High School.[2] He completed a dual Bachelor of Science–Master of Science program in chemistry and biochemistry at the University of Chicago from 1980 to 1984.[3] There he began his research career, working in the laboratories of organic chemist Josef Fried, biochemist Kan Agarwal, and bacteriologist Malcolm Casadaban.[2][4] In 1984, he began a dual MD–PhD program at Cornell Medical College and Rockefeller University, working on DNA repair in bacteria with Peter Model and Norton Zinder.[3] In 1989, after receiving his PhD from Rockefeller University, Heitman took a leave of absence from medical school to serve as an EMBO-sponsored long-term fellow at the Biozentrum University of Basel working with Michael N. Hall and Rao Movva applying yeast genetics to understand the mechanisms of action of immunosuppressive drugs.[3][5] This work led to the discovery of the cellular growth regulator TOR for which Michael Hall was awarded the Albert Lasker Award for Basic Medical Research in 2017.[6][7] In 1992, Heitman finished medical school and moved to Duke University to set up his own laboratory in the Department of Molecular Genetics and Microbiology.[3][4] He was an investigator with the Howard Hughes Medical Institute from 1992 to 2005 and a Burroughs Wellcome Scholar in Molecular Pathogenic Mycology from 1998 to 2005.[8] He became Chair of the Department of Molecular Genetics and Microbiology in 2009.[3] Since 2019, Heitman has been co-director of the Canadian Institute for Advanced Research's Fungal Kingdom program along with co-director Leah E. Cowen.[9]

Heitman's research has been recognized with prestigious awards and funding opportunities, including funding by the Howard Hughes Medical Institute from 1992 to 2005, and an National Institutes of Health MERIT Award from 2011-2021.[8][10] Several awards have recognized his research accomplishments, including the ASBMB AMGEN Award (2002), the IDSA Squibb Award (2003) (now called the Oswald Avery Award), the Stanley J. Korsmeyer Award (2018) (for key contributions to understanding how microbial pathogens evolve, cause disease, and develop drug resistance and discovery of TOR and FKBP12 as targets of rapamycin), the Rhoda Benham Award (2018), the Edward Novitski Prize (2019) (honoring work on human fungal pathogens and identifying molecular targets of widely used immunosuppressive drugs, a seminal contribution to discovery of TOR, which regulates cell growth in response to nutrients), the American Society for Microbiology's Award for Basic Research (2019), and the Distinguished Mycologist Award from the Mycological Society of America (2021).[11][12][13][14][15][16][17] Heitman is an elected fellow or member of the Infectious Diseases Society of America (2003), American Society for Clinical Investigation (2003), American Academy of Microbiology (2004), American Association for the Advancement of Science (2004), the Association of American Physicians (2006), the American Academy of Arts and Sciences (2020) [18][19], the National Academy of Sciences (2021) [20][21], the German National Academy of Sciences Leopoldina (2021) [22], and the National Academy of Medicine (2024). [23][24]

Research

[edit]

Heitman's research has largely focused on studies of model and pathogenic fungi to address unsolved problems in biology and medicine. Pioneering research with the model budding yeast Saccharomyces cerevisiae discovered TOR and FKBP12 as the targets of the immunosuppressive and antiproliferative drug rapamycin, now widely used in organ transplantation and cancer chemotherapy.[25][26] Later studies elucidated key features of how the TOR signaling pathway senses nutrients to control cellular responses.[27] Studies were conducted on the dimorphic transition of Saccharomyces cerevisiae from budding yeast cells to pseudohyphae, elucidating nutrient sensing signaling cascades governing this morphological transition involving GPCR-cAMP-PKA signaling cascades controlling gene expression, and discovering a novel role for the ammonium permease/Rh antigen homolog Mep2 as a transceptor for nitrogen source availability.[28][29][30][31][32][33][34]

Heitman's research program has also focused extensive studies on the pathogenesis, sexual cycle, and novel drug targets of the pathogenic fungus Cryptococcus.[3] His group described a previously unknown form of sexual reproduction in Cryptococcus species, known as unisexual reproduction, which involves both selfing sexual reproduction (homothallism) of isolates grown on their own without a mating partner, as well as sexual reproduction and recombination involving cell-cell fusion between individuals of the same mating type followed by meiosis and sporulation.[35][36] Studies conducted in parallel defined and illuminated evolution and function of fungal mating-type loci, illustrating parallels with sex chromosome evolution of plants and animals, including the discovery and characterization of the homeodomain proteins Sxi1alpha and Sxi2a, which coordinately control cell type identity and sexual reproduction.[37][38][39][40][41][42] Heitman's group has also had a long-standing interest in fungal evolution, describing how cellular processes such as sexual recombination and RNA interference are changed in different fungal lineages, as well as the expansion of the geographic range of the emerging pathogen Cryptococcus gattii.[3][36][43][44][45][46][47][48]

Roles as editor and in scientific publishing

[edit]

Joseph Heitman has served as co-editor of seven textbooks spanning microbiology, genetics, infectious diseases: The Fungal Kingdom, ASM Press October 2017, editors: Joseph Heitman, Barbara J. Howlett, Pedro W. Crous, Eva H. Stukenbrock, Timothy Yong James, and Neil A.R. Gow.;[49] Sex in Fungi: Molecular Determination and Evolutionary Implications, ASM Press 2007, editors: Joseph Heitman, James W. Kronstad, John W. Taylor, and Lorna A. Casselton.;[50] Cryptococcus: From Human Pathogen to Model Yeast, ASM Press 2011, editors: Joseph Heitman, Thomas R. Kozel, Kyung J. Kwon-Chung, John R. Perfect, and Arturo Casadevall.;[51] Molecular Principles of Fungal Pathogenesis, ASM Press 2006, editors: Joseph Heitman, Scott G. Filler, John E. Edwards Jr., and Aaron P. Mitchell.;[52] Human Fungal Pathogens, Cold Spring Harbor Laboratory Press, 2015, editors: Arturo Casadevall, Aaron P. Mitchell, Judith Berman, Kyung J. Kwon-Chung, John R. Perfect, and Joseph Heitman.;[53] Evolution of Virulence in Eukaryotic Microbes, Wiley Press June 2012, editors: L. David Sibley, Barbara J. Howlett, and Joseph Heitman.;[54] and Yeast as a Tool in Cancer Research, Springer Press, 2007, editors: John L. Nitiss and Joseph Heitman.[55]

Joseph Heitman serves as an editor for journals including PLOS Pathogens, PLOS Genetics, mBio, Fungal Genetics & Biology, and Frontiers Cellular and Infection Microbiology | Fungal Pathogenesis,[56][57][58][59][60] and from 2006 to present on the editorial boards for the journals Current Biology, Cell Host & Microbe, and PLOS Biology.[61][62][63]

References

[edit]
  1. ^ "Joseph Heitman, MD, PhD". Duke University School of Medicine. Retrieved 23 July 2019.
  2. ^ a b Williams, Corinne L. (2018). "Talking TOR: A conversation with Joe Heitman and Rao Movva". JCI Insight. 3 (4). doi:10.1172/jci.insight.99816. PMC 5916239. PMID 29467327.
  3. ^ a b c d e f g "Joseph Heitman, MD, PhD - Biography". Duke University School of Medicine. Retrieved 23 July 2019.
  4. ^ a b Jackson, Sarah (2018). "Joseph Heitman receives the 2018 ASCI/Korsmeyer Award". Journal of Clinical Investigation. 128 (4): 1205–1207. doi:10.1172/JCI120588. PMC 5873853. PMID 29608142.
  5. ^ Heitman, Joseph (2015). "On the Discovery of TOR as the Target of Rapamycin". PLOS Pathogens. 11 (11): e1005245. doi:10.1371/journal.ppat.1005245. PMC 4634758. PMID 26540102.
  6. ^ "2017 Lasker Awards". Albert and Mary Lasker Foundation. Retrieved 23 July 2019.
  7. ^ Heitman J, Movva NR, Hall MN (August 1991). "Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast". Science. 253 (5022): 905–9. Bibcode:1991Sci...253..905H. doi:10.1126/science.1715094. PMID 1715094. S2CID 9937225.
  8. ^ a b "Joseph Heitman, MD, PhD HHMI alumnus investigator". Howard Hughes Medical Institute. Retrieved 23 May 2020.
  9. ^ "Heitman and Cowen Awarded CIFAR for Research Program "The Fungal Kingdom: Threats & Opportunities"". Duke University Medical School. 8 April 2019. Archived from the original on 27 September 2019. Retrieved 12 September 2019.
  10. ^ "duke-physician-scientist-receives-prestigious-nih-merit-award-studies-fungal-unisexual". Duke Health. 21 June 2011. Retrieved 23 May 2020.
  11. ^ "Molecular Biologist Receives Commendation". Duke University News. 27 August 2001. Retrieved 2 October 2020.
  12. ^ "IDSA Award Recipients". Infectious Diseases Society of America. Retrieved 2 October 2020.
  13. ^ "Stanley J. Korsmeyer Award". American Society for Clinical Investigation. Retrieved 12 September 2019.
  14. ^ "Rhoda Benham Award Recipients". Medical Mycological Society of America. Retrieved 2 October 2020.
  15. ^ Heitman J (September 2019). "E pluribus unum: the fungal kingdom as a Rosetta Stone for biology and medicine". Genetics. 213 (1): 1–7. doi:10.1534/genetics.119.302537. PMC 6727799. PMID 31488591.
  16. ^ "ASM Award Recipients". American Society for Microbiology. Retrieved 15 January 2020.
  17. ^ "MSA Award Recipient". Duke University School of Medicine. 11 August 2021. Retrieved 14 August 2021.
  18. ^ "price-kornbluth-and-six-senior-faculty-join-american-academy-arts-sciences". Duke University. 23 April 2020. Retrieved 26 April 2020.
  19. ^ "new-members-2020". American Academy of Arts and Sciences. Retrieved 26 April 2020.
  20. ^ "two duke faculty elected national academy of sciences". Duke University. 27 April 2021. Retrieved 29 April 2021.
  21. ^ "news/2021/ nas election". National Academy of Sciences. Retrieved 29 April 2021.
  22. ^ "List of Members". Leopoldina. Retrieved 11 November 2024.
  23. ^ "Heitman Elected to National Academy of Medicine". Duke University School of Medicine. 21 October 2024. Retrieved 11 November 2024.
  24. ^ "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. 21 October 2024. Retrieved 11 November 2024.
  25. ^ Heitman, J, Movva, NR, Hiestand, PC, Hall, MN (March 1991). "FK506-binding protein proline rotamase is a target for the immunosuppressive agent FK506 in Saccharomyces cerevisiae". Proc Natl Acad Sci U S A. 88 (5): 1948–1952. Bibcode:1991PNAS...88.1948H. doi:10.1073/pnas.88.5.1948. PMC 51143. PMID 1705713.
  26. ^ Heitman, J, Movva, NR, Hall, MN (August 23, 1991). "Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast". Science. 253 (5022): 905–909. Bibcode:1991Sci...253..905H. doi:10.1126/science.1715094. PMID 1715094. S2CID 9937225.
  27. ^ Cardenas ME, Cutler NS, Lorenz MC, Di Como CJ, Heitman J (December 1999). "The TOR signaling cascade regulates gene expression in response to nutrients". Genes Dev. 13 (24): 3271–3279. doi:10.1101/gad.13.24.3271. PMC 317202. PMID 10617575.
  28. ^ Lorenz, MC, Heitman, J (December 1997). "Yeast pseudohyphal growth is regulated by GPA2, a G protein alpha homolog". EMBO Journal. 16 (23): 7008–7018. doi:10.1093/emboj/16.23.7008. PMC 1170304. PMID 1705713.
  29. ^ Lorenz, MC, Heitman, J (August 1998). "The MEP2 ammonium permease regulates pseudohyphal differentiation in Saccharomyces cerevisiae". EMBO Journal. 17 (5): 1236–1247. doi:10.1093/emboj/17.5.1236. PMC 1170472. PMID 9482721.
  30. ^ Lorenz, MC, Pan, X, Harashima, T, Cardenas, ME, Xue, Y, Hirsch, JP, Heitman, J (February 2000). "The G protein-coupled receptor Gpr1 is a nutrient sensor that regulates pseudohyphal differentiation in Saccharomyces cerevisiae". Genetics. 154 (2): 609–622. doi:10.1093/genetics/154.2.609. PMC 1460933. PMID 10655215.
  31. ^ Pan, X, Heitman, J (July 1999). "Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae". Mol Cell Biol. 19 (7): 4874–4887. doi:10.1128/mcb.19.7.4874. PMC 84286. PMID 10373537.
  32. ^ Pan, X, Heitman, J (June 2002). "Protein kinase A operates a molecular switch that governs yeast pseudohyphal differentiation". Mol Cell Biol. 22 (12): 3981–3993. doi:10.1128/mcb.22.12.3981-3993.2002. PMC 133872. PMID 12024012.
  33. ^ Pan, X, Harashima, T, Heitman, J (December 2000). "Signal transduction cascades regulating pseudohyphal differentiation of Saccharomyces cerevisiae". Curr Opin Microbiol. 3 (6): 567–572. doi:10.1016/s1369-5274(00)00142-9. PMID 11121775.
  34. ^ Lengeler, KB, Davidson, RC, D'souza, C, Harashima, T, Shen, WC, Wang, P, Pan, X, Waugh, M, Heitman, J (December 2000). "Signal transduction cascades regulating fungal development and virulence". Microbiol Mol Biol Rev. 64 (4): 746–785. doi:10.1128/mmbr.64.4.746-785.2000. PMC 99013. PMID 11104818.
  35. ^ Lin, X, Hull, CM, Heitman J (April 2005). "Sexual reproduction between partners of the same mating type in Cryptococcus neoformans". Nature. 434 (7036): 1017–21. Bibcode:2005Natur.434.1017L. doi:10.1038/nature03448. PMID 15846346. S2CID 52857557.
  36. ^ a b "2019 Edward Novitski Prize awarded to Joseph Heitman". Genetics Society of America. 12 February 2019. Retrieved 23 July 2019.
  37. ^ Lengeler KB, Fox DS, Fraser JA, Allen A, Forrester K, Dietrich FS, Heitman J (October 2002). "Mating-type locus of Cryptococcus neoformans: a step in the evolution of sex chromosomes". Eukaryotic Cell. 1 (5): 704–718. doi:10.1128/ec.1.5.704-718.2002. PMC 126754. PMID 12455690.
  38. ^ Fraser, JA, Diezmann, S, Subaran, RL, Allen, A, Lengeler, KB, Dietrich, FS, Heitman, J (December 2004). "Convergent evolution of chromosomal sex-determining regions in the animal and fungal kingdoms". PLOS Biology. 2 (12): e384. doi:10.1371/journal.pbio.0020384. PMC 526376. PMID 15538538.
  39. ^ Fraser, JA, Heitman, J (January 2004). "Evolution of fungal sex chromosomes". Molecular Microbiology. 51 (2): 299–306. CiteSeerX 10.1.1.474.9652. doi:10.1046/j.1365-2958.2003.03874.x. PMID 14756773. S2CID 2467616.
  40. ^ Fraser, JA, Heitman, J (September 2005). "Chromosomal sex-determining regions in animals, plants and fungi". Curr Opin Genet Dev. 15 (6): 645–651. doi:10.1016/j.gde.2005.09.002. PMID 16182521.
  41. ^ Hull, CM, Davidson, RC, Heitman, J (December 2002). "Cell identity and sexual development in Cryptococcus neoformans are controlled by the mating-type-specific homeodomain protein Sxi1alpha". Genes Dev. 16 (23): 3046–3060. doi:10.1101/gad.1041402. PMC 187491. PMID 12464634.
  42. ^ Hull, CM, Boily, MJ, Heitman, J (March 2005). "Sex-specific homeodomain proteins Sxi1alpha and Sxi2a coordinately regulate sexual development in Cryptococcus neoformans". Eukaryotic Cell. 4 (3): 526–535. doi:10.1128/EC.4.3.526-535.2005. PMC 1087792. PMID 15755915.
  43. ^ Calo S, Shertz-Wall C, Lee SC, Bastidas RJ, Nicolás FE, Granek JA, Mieczkowski P, Torres-Martínez S, Ruiz-Vázquez RM, Cardenas ME, Heitman J (September 2014). "Antifungal drug resistance evoked via RNAi-dependent epimutations". Nature. 513 (7519): 555–8. Bibcode:2014Natur.513..555C. doi:10.1038/nature13575. PMC 4177005. PMID 25079329.
  44. ^ Wang, X, Hsueh, YP, Li, W, Floyd, A, Skalskey, R, Heitman J (November 2010). "Sex-induced silencing defends the genome of Cryptococcus neoformans via RNAi". Genes & Development. 24 (22): 2566–82. doi:10.1101/gad.1970910. PMC 2975932. PMID 21078820.
  45. ^ Feretzaki, M, Billmyre, RB, Clancey, SA, Wang, X, Heitman J (April 2005). "Gene network polymorphism illuminates loss and retention of novel RNAi silencing components in the Cryptococcus pathogenic species complex". PLOS Genetics. 12 (3): e1005868. doi:10.1371/journal.pgen.1005868. PMC 4778953. PMID 26943821.
  46. ^ Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, Allen A, Stajich JE, Dietrich FS, Perfect JR, Heitman J (October 2005). "Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak". Nature. 437 (7063): 1360–4. Bibcode:2005Natur.437.1360F. doi:10.1038/nature04220. PMID 16222245. S2CID 4358966.
  47. ^ Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J (April 2009). "Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States". J Infect Dis. 199 (7): 1081–6. doi:10.1086/597306. PMC 2715219. PMID 19220140.
  48. ^ Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, Ren P, Carter DA, Chaturvedi V, Bildfell RJ, May RC, Heitman J (April 2010). "Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States". PLOS Pathog. 6 (4): e1000850. doi:10.1371/journal.ppat.1000850. PMC 2858702. PMID 20421942.
  49. ^ Heitman; Howlett; Crous; Stukenbrock; James; Gow, eds. (2017). textbook The Fungal Kingdom. ASM. doi:10.1128/9781555819583. ISBN 9781555819576. Retrieved 15 March 2020.
  50. ^ Heitman, Joseph; Kronstad, James W; Taylor, John W; Casselton, Lorna A, eds. (2007). textbook Sex in Fungi. ASM. doi:10.1128/9781555815837. ISBN 9781683671602. Retrieved 15 March 2020.
  51. ^ Heitman, Joseph; Kozel, Thomas R; Kwon-Chung, Kyung J; Perfect, John R; Casadevall, Arturo, eds. (2010). textbook Cryptococcus. ASM. doi:10.1128/9781555816858. ISBN 9781683671220. Retrieved 15 March 2020.
  52. ^ Heitman, Joseph; Filler, Scott G; Edwards, John E; Mitchell, Aaron P, eds. (2006). textbook Molecular Principles of Fungal Pathogenesis. ASM. doi:10.1128/9781555815776. ISBN 9781683671800. Retrieved 15 March 2020.
  53. ^ "textbook Human Fungal Pathogens". CSHL Press. Retrieved 15 March 2020.
  54. ^ "textbook on Evolution of Microbial Virulence". Wiley Press. Retrieved 15 March 2020.
  55. ^ Nitiss, John L; Heitman, Joseph, eds. (2007). textbook on Yeast as a model for cancer research. Springer Press. doi:10.1007/978-1-4020-5963-6. ISBN 978-1-4020-5962-9. Retrieved 15 March 2020.
  56. ^ "PLOS Pathogens editorial board". Retrieved March 16, 2021.
  57. ^ "PLOS Genetics editorial board". Retrieved March 16, 2021.
  58. ^ "mBio Board of Editors". Retrieved March 16, 2021.
  59. ^ "Fungal Genetics & Biology board of editors". Retrieved March 16, 2021.
  60. ^ "Co-Editor in Chief, Frontiers Cellular and Infection Microbiology Fungal Pathogenesis section". Retrieved March 16, 2021.
  61. ^ "Current Biology editorial board". Retrieved March 16, 2021.
  62. ^ "Cell Host & Microbe editorial board". Retrieved March 16, 2021.
  63. ^ "PLOS Biology board of editors". Retrieved March 16, 2021.
[edit]
Retrieved from "http://en.wiki.x.io/w/index.php?title=Joseph_Heitman&oldid=1256811177"